Survey of the management of patients with bronchiectasis: a pilot investigation in Asian populations
- Author:
Ho Cheol KIM
1
;
Masaru SUZUKI
;
Hui Fang LIM
;
Le Thi Tuyet LAN
;
Ho Lam NGUYEN
;
Jeng-Shing WANG
;
Kang-Yun LEE
;
Jae Seung LEE
;
Yeon-Mok OH
;
Sang Do LEE
;
Hayoung CHOI
;
Hyun LEE
;
Sei Won LEE
Author Information
- Publication Type:2
- From:The Korean Journal of Internal Medicine 2021;36(6):1402-1409
- CountryRepublic of Korea
- Language:English
-
Abstract:
Background/Aims:Although international guidelines for bronchiectasis management have been published in Western countries, there is a lack of data about their application in Asian populations including patients with different phenotypes. We aimed to investigate the current status of bronchiectasis management in Asian populations.
Methods:A nationwide questionnaire survey was performed of Asian respiratory specialists from South Korea, Japan, Taiwan, Singapore, Vietnam, and Sri Lanka. Participants were invited by e-mail to answer a questionnaire comprising 25 questions based on international guidelines for the management of bronchiectasis.
Results:A total of 221 physicians participated in the survey. About half of them were Korean (50.2%), with the next most common nationalities being Japanese (23.1%), Taiwanese (13.6%), and Singaporean (7.7%). Only 18 (8.1%) responders had local guidelines for bronchiectasis. While 85 (38.5%) responders checked sputum acid-fast bacillus smear/culture about 1 to 3 times per year, only a small proportion of responders routinely performed a serum immunoglobulin test (36/221, 16.3%) or evaluated for allergic bronchopulmonary aspergillosis (41/221, 18.6%). Less than half (43.4%) of responders performed eradication treatment in patients with drug-sensitive Pseudomonas aeruginosa infection, mainly due to the limited availability of inhaled antibiotics (34.8%). In addition, 58.6% of responders considered physiotherapy such as airway clearance and pulmonary rehabilitation.
Conclusions:Discrepancies might exist between guideline recommendations and practice for bronchiectasis management in Asian populations, partly due to the limited availability of treatment in each country. The development of local guidelines that consider the phenotypes and situation will help to standardize and improve the management of bronchiectasis.
